Why TikTok Removes Mounjaro and Weight Loss Content

The law behind the removals

Under the Human Medicines Regulations 2012, a prescription-only medicine cannot be advertised to the general public. Information for healthcare professionals is treated differently, and factual, non-promotional information is not the same as an advert, but the boundary is narrower than most people assume. Naming the medicine alongside a price, an offer, a discount code or a call to action is advertising.

The MHRA enforces this, and the ASA applies the CAP Code to marketing communications. Both have acted on GLP-1 promotion in recent years, including against pharmacies and against influencer posts. Our guide to skinny jab marketing and the advertising ban covers what pharmacies can and cannot say.

Two consequences follow that surprise people. First, a pharmacy cannot lawfully run a TikTok advert saying “Mounjaro from £X”. Second, an influencer or affiliate promoting that pharmacy is subject to the same restriction, and disclosure does not fix it, because the problem is the promotion itself rather than the failure to disclose.

Why enforcement catches the wrong content

Platforms cannot review every post individually, so they moderate at the level of terms and patterns. A system that can reliably remove “Mounjaro, link in bio” cannot reliably distinguish it from “week three on Mounjaro and the nausea has eased”. Both contain the same brand name in the same category.

The predictable effects are:

• Patient accounts removed or suppressed for describing their own treatment, which is not advertising by any reading of the law.
• Registered pharmacies restricted even when posting compliant, non-promotional information.
• Safety content caught, including warnings about counterfeit pens and unregistered sellers, because it also names the medicine.
• Uneven outcomes. Small accounts are removed quickly; larger, well-resourced advertisers tend to survive longer, appeal more effectively, and adapt faster.

The rule itself is reasonable. Blanket keyword enforcement of it is not the same thing as good enforcement, and the gap is where patients lose out.

What is lost when the conversation goes

Regulators are largely reactive. The MHRA acts once a problem is reported, which means somebody has to notice and report it. In practice the first warnings about a counterfeit batch, a pharmacy that ships without cold-chain packaging or a site taking payment without a consultation come from patients talking to each other.

The February 2026 falsified 15mg pens are a case in point: community reporting on Reddit spread the warning quickly and widely. When that discussion is removed from a platform, the counterfeit sellers, who do not rely on discoverable posts anyway and operate through direct messages, are the least affected.

If your content was removed

• Appeal in the app. TikTok restores content on appeal often enough to be worth the two minutes. Say plainly that the post describes personal experience and does not promote or sell a medicine.
• Remove the promotional signals if you want the post to survive: no price, no discount code, no affiliate link, no “DM me”, no pharmacy tag.
• If you are a pharmacy, take advice on the advertising rules before posting. A removal is the least serious outcome; an MHRA or ASA ruling is not.
• Keep a copy. Screenshot the post and the removal notice before appealing.

Where to get reliable information instead

Platform moderation is not a substitute for a source you can check. For the medicine itself, the patient information leaflet is the definitive document. For safety alerts, the MHRA publishes drug safety updates and runs the Yellow Card scheme. For whether a seller is real, check the GPhC register and our guide to checking a pharmacy is genuine. For prices, our price list shows totals across verified pharmacies.

And treat any social media post offering a prescription medicine for sale as a warning sign rather than a bargain, whatever the platform has or has not removed.